IPRIFLAVONE - NEW INSIGHTS INTO ITS MECHANISMS OF ACTION ON BONE REMODELING

被引：11

作者：

BRANDI, ML ^{[1
]}

GENNARI, C ^{[1
]}

机构：

[1] UNIV SIENA,SCH MED,INST CLIN METHODOL,I-53100 SIENA,ITALY

来源：

CALCIFIED TISSUE INTERNATIONAL | 1993年 / 52卷 / 02期

关键词：

D O I：

10.1007/BF00308326

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：151 / 151

页数：1

共 15 条

[1]

AGNUSDEI D, 1989, DRUG EXP CLIN RES, V15, P97

[2]

AGNUSDEI D, 1992, CURR THER RES, V52, P81

[3]

AGNUSDEI D, 1992, BONE MINER, V19, P543

[4]

BENVENUTI S, 1991, J BONE MINER RES, V6, P987

[5] IPRIFLAVONE INHIBITS OSTEOCLAST DIFFERENTIATION IN PARATHYROID TRANSPLANTED PARIETAL BONE OF RATS [J].

BONUCCI, E ;

BALLANTI, P ;

MARTELLI, A ;

MERETO, E ;

BRAMBILLA, G ;

BIANCO, P ;

BUFALINO, L .

CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (04) :314-319

[6] OSTEOCLAST FORMATION FROM MONONUCLEAR PHAGOCYTES - ROLE OF BONE-FORMING CELLS [J].

BURGER, EH ;

VANDERMEER, JWM ;

NIJWEIDE, PJ .

JOURNAL OF CELL BIOLOGY, 1984, 99 (06) :1901-1906

[7]

FUJITA T, 1985, PROG MED, V5, P2959

[8] OSTEOBLAST-LIKE CELLS IN THE PRESENCE OF PARATHYROID-HORMONE RELEASE SOLUBLE FACTOR THAT STIMULATES OSTEOCLASTIC BONE-RESORPTION [J].

MCSHEEHY, PMJ ;

CHAMBERS, TJ .

ENDOCRINOLOGY, 1986, 119 (04) :1654-1659

[9]

ORIMO H, 1985, PROG MED, V5, P2943

[10]

RIBARI O, 1987, ACTA OTOLARYNGOL, V103, P675

← 1 2 →